CLASS ACTION UPDATE for OMCL, CURLF, PS and WFTIQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Omnicell, Inc. OMCL
Class Period: October 25, 2018 - July 11, 2019
Lead Plaintiff Deadline: September 16, 2019
Join the action: https://www.zlk.com/pslra-1/omnicell-inc-loss-form?wire=3

Allegations: Omnicell, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) the Company recognized revenue for certain transactions before fulfilling its performance obligations; (2) the Company engaged in improper accounting practices to meet revenue targets; (3) the Company experienced weaker demand for new product lines than it had previously projected; (4) as a result, the Company would be required to write-off certain inventory; (5) the Company misclassified certain expenses as capitalized expenditures; and (6) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more about the Omnicell, Inc. class action contact jlevi@levikorsinsky.com.

Curaleaf Holdings, Inc. CURLF
Class Period: November 21, 2018 - July 22, 2019
Lead Plaintiff Deadline: October 4, 2019
Join the action: https://www.zlk.com/pslra-1/curaleaf-holdings-inc-loss-form?wire=3

Allegations: During the class period, Curaleaf Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that:  (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the Curaleaf Holdings, Inc. class action contact jlevi@levikorsinsky.com.

Pluralsight, Inc. PS
Class Period: August 2, 2018 - July 31, 2019
Lead Plaintiff Deadline: October 15, 2019
Join the action: https://www.zlk.com/pslra-1/pluralsight-inc-loss-form?wire=3

According to the filed complaint, the Company failed to disclose that Pluralsight was experiencing substantial delays in hiring and properly training the salesforce necessary to meet its lofty billing projections. In addition, the Company knew at the time of the March 2019 secondary public offering ("SPO")  that it was behind schedule onboarding new sales representatives, which was hurting the Company's sales execution and preventing Pluralsight from meeting its high growth projections. Instead of disclosing such facts at the time of the SPO, and to cash-out at inflated prices, Defendants intentionally obscured and omitted this pertinent information from investors.

To learn more about the Pluralsight, Inc. class action contact jlevi@levikorsinsky.com.

Weatherford International plc WFTIQ
Class Period: (i) during the period from October 26, 2016 through May 10, 2019, inclusive; and/or (ii) pursuant or traceable to Weatherford's secondary offering of common stock that closed on or about November 21, 2016.
Lead Plaintiff Deadline: November 5, 2019
Join the action: https://www.zlk.com/pslra-1/weatherford-international-plc-loss-form?wire=3

According to a filed complaint, during the Class Period, certain individuals in Weatherford's management, certain of its directors, and an underwriter made materially false and misleading statements and omitted material adverse facts concerning Weatherford's "recovery" and "transformation plan" and, relatedly, the Company's ability to manage its debt and avoid bankruptcy. As a result of these misstatements and/or omissions, Weatherford's securities traded at artificially inflated prices during the Class Period.

To learn more about the Weatherford International plc class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com